TYCHE INDUSTRIES
|
The Current P/E Ratio of TYCHE INDUSTRIES is 18.72.
| Share Price | ₹126.0 | Jun 10,2026 |
| Market Cap | ₹129.7 Cr | |
| Earnings-TTM | ₹6.9 Cr | TTM-Standalone Results |
| Price/Earnings | 18.72x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of TYCHE INDUSTRIES
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹129.7 Cr] as on Jun 10,2026
(/) Earnings [ ₹6.9 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 18.72x ]
Thus, for TYCHE INDUSTRIES , the investors are currently willing to pay 18.72 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of TYCHE INDUSTRIES !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of TYCHE INDUSTRIES over the last five years.
Historical PE (Price/Earnings) ratio chart of TYCHE INDUSTRIES
PE Ratio Performance Analysis for TYCHE INDUSTRIES
- TYCHE INDUSTRIES 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 11.94x.
- TYCHE INDUSTRIES 's operated at median p/e ratio of 10.99x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, TYCHE INDUSTRIES 's p/e ratio peaked in Mar2022 at 15.17x.
- TYCHE INDUSTRIES 's p/e ratio hit its five-year low in Mar2021 of 8.74x.
How does TYCHE INDUSTRIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| TYCHE INDUSTRIES | 6.93 | 18.72 | 129.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,564.50 | 37.08 | 428,785.0 |
| DIVIS LABORATORIES LTD | 2,568.00 | 68.63 | 176,242.0 |
| TORRENT PHARMACEUTICALS LTD | 2,138.00 | 70.65 | 151,058.0 |
| CIPLA LTD | 3,869.79 | 28.73 | 111,180.0 |
| DR REDDYS LABORATORIES LTD | 4,144.20 | 25.61 | 106,149.0 |
| MANKIND PHARMA LTD | 1,926.41 | 50.85 | 97,952.3 |
| LUPIN LTD | 5,355.47 | 19.20 | 102,818.0 |
| ZYDUS LIFESCIENCES LTD | 5,026.40 | 21.98 | 110,474.0 |
| AUROBINDO PHARMA LTD | 3,501.45 | 23.89 | 83,654.2 |
| LAURUS LABS LTD | 889.85 | 84.09 | 74,827.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs TYCHE INDUSTRIES 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.72x |
| Max industry PE | 84.09x |
| Median industry PE | 28.73x |
| Average industry PE | 40.86x |
You may also like the below Video Courses